Processed commodity	Number of valid studiesa	Processing Factor (PF)		CFP c	Comment/Source
		Individual valuesb	Median PF
PFs derived for imazalil in the MRL review CFp to be calculated, once a decision on the residue definition for risk assessment for Po‐use is derived
Citrus, peeled	36d	0.01; 0.01; 0.01; 0.02; 0.03; 0.04; 0.04; 0.04; 0.04; 0.04; 0.04; 0.04; 0.05; 0.05; 0.05; 0.05; 0.06; 0.07; 0.07; 0.07; 0.08; 0.08; 0.08; 0.08; 0.10; 0.11; 0.12; 0.13; 0.14; 0.15; 0.15; 0.16; 0.20; 0.21; 0.25; 0.28	0.07	TBE	EFSA (2017a,b)
Oranges, juice	10	0.01; 0.02; 0.03; 0.05; 0.05; 0.10; 0.11; 0.14; 0.33; 0.35	0.08	TBE	EFSA (2017a,b)
Oranges, dry pomace	10	1.0; 1.1; 2.3; 4.03; 4.05; 4.39; 4.48; 4.86; 6.70; 9.56	4.20	TBE	EFSA (2017a,b)
Oranges, wet pomace	7	1.74; 1.98; 2.03; 2.04; 2.20; 2.29; 2.72	2.00	TBE	EFSA (2017a,b)
Oranges, marmalade	7	0.15; 0.25; 0.25; 0.27; 0.28; 0.56; 0.68	0.27	TBE	EFSA (2017a,b)

MRL: maximum residue level.

^aStudies with residues in the RAC at or close to the LOQ were disregarded (unless concentration may occur).

^bIn bold, samples analysed also for R014821. Residues were: 2 × 0.02 mg/kg in the RAC (WP 31 days), 2 × < 0.01 mg/kg in juice, 0.18 and 0.28 mg/kg in dry pomace, 0.05 and 0.08 mg/kg in wet pomace, < 0.01 and 0.01 mg/kg in marmalade (Netherlands, 2015).

^cConversion factor for risk assessment in the processed commodity. To be established (TBE) upon decision on a residue definition for risk assessment for Po‐use in citrus fruits.

^dBased on residue trials compliant with the Po GAP (drenching, 50 g/hL; WP 0 days, including replicates) performed on oranges (n=15, ranging from 0.01 to 0.28) and mandarins (n=16, ranging from 0.01 to 0.25) (EFSA, 2017a,b) and considering the PFs derived during the peer review on oranges (0.08), lemons (0.04; 0.04; 0.05) and grapefruits (0.13) (EFSA, 2010).